GLP-1 drugs’ recent blockbuster appeal has already changed the way providers and pharmacists are doing their jobs, but the American Hospital Association says their appeal could shift other aspects of hospital operations too.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
